Brain science learns about sight from computer science—and vice versa

Researchers studying the basis of visual recognition in two distinct disciplines—computer science and brain science—have put their heads together to advance both fields at once.

Specifically, they’ve captured the brain activity of four people viewing each image in a 5,000-image set, then drawn from a deep-learning algorithm trained on the same image set to better understand how the brain processes visual information.

The hope is that this insight, in turn, will symbiotically improve deep-learning methodologies going forward.  

The team, comprising experts from Carnegie Mellon University in Pittsburgh and Fordham University in New York City, described their work in a study published online May 6 in Scientific Data.

The four volunteers who viewed the images underwent functional MRI (fMRI) brain scanning totaling at least 20 hours each.

“The extreme design decision to run the same individuals over so many sessions was necessary for disentangling the neural responses associated with individual images,” the team explained in a news release sent by Carnegie Mellon.

“As we learn more about the neural basis of visual recognition, we will also be better positioned to contribute to advances in artificial vision,” added study co-author Michael Tarr, who heads Carnegie Mellon’s psychology department.

Tarr pointed out that, while the study’s image dataset was hefty relative to others used in prior research, much larger sets are needed to advance computer-vision models as well as neuroscience’s understanding of biological vision.

A reasonable fMRI dataset “would require at least 50,000 stimulus images and many more volunteers to make headway in light of the fact that the class of deep neural nets used to analyze visual imagery are trained on millions of images,” Tarr said.

Click here to read the full study for free and here for the news release.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup